Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement | Contract Pharma
Breaking News

AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement

Expands scope of Aji Bio-Pharma's service offerings to include aseptic fill finish services at its San Diego, CA facility.

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, entered an expanded manufacturing agreement with AstraZeneca to include drug product manufacturing.
 
This agreement expands the scope of Aji Bio-Pharma’s service offerings to AstraZeneca to include aseptic fill finish services at its San Diego, CA facility, in addition to small molecule manufacturing services proceeding in Belgium.
 
“We are excited to expand our manufacturing agreement with AstraZeneca and to support them with additional service offerings,” said Magnus Busch, Global Account Manager, Ajinomoto Bio-Pharma Services. “Our San Diego team is proud to join our Belgium colleagues in support of AstraZeneca. This expanded agreement builds on our commitment to be a leading, trusted, innovative partner to our clients.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters